Skip to content

Clinical evaluation of Chinese combined with Western medicine on effects of diminished ovarian reserve

Clinical evaluation of Chinese combined with Western medicine on effects of diminished ovarian reserve

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020548
Enrollment
Unknown
Registered
2019-01-08
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diminished ovariana reserve

Interventions

1:Ding Kun Dan for 3 months then Ding Kun Dan and Letrozole for 3 months
2:Ding Kun Dan for 3 months then placebo and Letrozole for 3 months
3:Placebo for 3 months then placebo and Letrozole for 3 months
4:Placebo for 3 months then Ding Kun Dan and Letrozole for 3 months

Sponsors

Peking Union Medical College Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) infertility female aged between 22 and 39 years; (2) meet DOR diagnostic criteria in Western medicine; (3) meet kidney deficiency diagnostic criteria in Chinese medicine; (4) willing and able to give informed consent.

Exclusion criteria

Exclusion criteria: (1) premature ovarian insufficiency, premature ovarian failure, ovarian tumor, endometrial tuberculosis, endometrial adhesion or endometrial lesion; congenital adrenal cortical hyperplasia, Cushing's syndrome; (2) iatrogenic DOR, such as pelvic surgery, radiotherapy, chemotherapy or uterine artery embolization, etc.; (3) Infertility due to tubal, uterine, cervical lesions; (4) Infertility due to male factors; (5) Severe cardio, liver, kidney diseases and any kind of malignancy; (6) Mental disorders; (7) Participated in and other clinical trials or used any hormonal drugs or any Chinese medicine within 1 months prior to study entry; (8) Allergic to any ingredient of the drug.

Design outcomes

Primary

MeasureTime frame
clinical pregnancy rate;

Secondary

MeasureTime frame
AMH;AFC;

Countries

China

Contacts

Public ContactSun Aijun

Peking Union Medical College Hospital

18518754255@163.com+86 18518754255

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026